Position in BSX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$285,699
-$166,916 QoQ
Shares Held
6,694
-7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,040
of 1,474 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $11,099,601 across 12 Medical Devices names. BSX ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
13,851 | $4,360,848 | |
| 2 | MDT |
Medtronic plc
|
32,300 | $2,526,829 | |
| 3 | ABT |
Abbott Laboratories
|
15,222 | $1,381,244 | |
| 4 | BRKR |
Bruker Corp
|
16,085 | $967,995 | |
| 5 | QDEL |
QuidelOrtho Corp
|
26,918 | $471,603 | |
| 6 | EW |
Edwards Lifesciences Corp
|
3,683 | $333,164 | |
| 7 | BSX |
Boston Scientific Corp
This page
|
6,694 | $285,699 | |
| 8 | GMED |
Globus Medical Inc
|
3,409 | $269,345 |
All Filings in BSX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,699 | 6,694 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $452,615 | 7,213 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,169,467 | 12,265 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,618,510 | 16,578 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $366,375 | 3,411 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $383,545 | 3,802 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $345,579 | 3,869 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $335,786 | 4,007 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $295,872 | 3,842 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $258,001 | 3,767 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $223,493 | 3,866 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||